nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An antigenic chimaera of poliovirus type 1 expressing an epitope from human papillomavirus type 16
|
Jenkins, O. |
|
1989 |
7 |
2 |
p. 184- 1 p. |
artikel |
2 |
A nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers
|
Stroffolini, Tommaso |
|
1989 |
7 |
2 |
p. 152-154 3 p. |
artikel |
3 |
Anti-fertility vaccines
|
Talwar, G.P. |
|
1989 |
7 |
2 |
p. 97-101 5 p. |
artikel |
4 |
Attenuated cytomegalovirus capable of cellular infection containing a foreign gene capable of expression in a cytomegalovirus-infected host cell; potential vaccine
|
|
|
1989 |
7 |
2 |
p. 161- 1 p. |
artikel |
5 |
Attenuated vaccinia virus recombinant containing a lymphokine, especially interleukin-2, gene and optionally foreign antigen genes; useful for making vaccine
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
6 |
A vaccine to genital papillomaviruses: is it feasible?
|
McCance, D.J. |
|
1989 |
7 |
2 |
p. 183- 1 p. |
artikel |
7 |
Calendar
|
|
|
1989 |
7 |
2 |
p. 192- 1 p. |
artikel |
8 |
Candidate vaccines for HIV
|
Girard, Marc |
|
1989 |
7 |
2 |
p. 188-189 2 p. |
artikel |
9 |
Cattle leukaemia vaccine containing recombinant vaccinia virus incorporating cattle leukaemia virus surface antigen gene
|
|
|
1989 |
7 |
2 |
p. 162- 1 p. |
artikel |
10 |
Cell- and serum-mediated protection against Chlamydia psittaci infection of the mouse
|
Buzoni-Gatel, D. |
|
1989 |
7 |
2 |
p. 178-179 2 p. |
artikel |
11 |
Cellular and molecular approaches to the development of a vaccine for syphilis: current status and prospects for the future
|
Miller, James N. |
|
1989 |
7 |
2 |
p. 180- 1 p. |
artikel |
12 |
Characterization of an HSV-1 subunit vaccine and its enhanced immunogenicity in the form of an immunostimulating complex preparation
|
Erturk, M.A. |
|
1989 |
7 |
2 |
p. 186- 1 p. |
artikel |
13 |
Cloned DNA to lassavirus nucleoprotein and glycoprotein gene used for the generation of live recombinant viruses for vaccines and diagnostic reagents
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
14 |
Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells
|
Ajjan, N. |
|
1989 |
7 |
2 |
p. 125-128 4 p. |
artikel |
15 |
Conference information
|
|
|
1989 |
7 |
2 |
p. 170- 1 p. |
artikel |
16 |
Conference programme
|
|
|
1989 |
7 |
2 |
p. 172-173 2 p. |
artikel |
17 |
Current and future hepatitis B vaccines
|
Zuckerman, Arie J. |
|
1989 |
7 |
2 |
p. 181- 1 p. |
artikel |
18 |
D.651, a vaccine for the prevention of recurrent vulvovaginal candidiasis
|
Levy, D.A. |
|
1989 |
7 |
2 |
p. 176- 1 p. |
artikel |
19 |
Development and Clinical studies with a recombinant DNA hepatitis B vaccine
|
Andre, F.E. |
|
1989 |
7 |
2 |
p. 181-182 2 p. |
artikel |
20 |
Development of a vaccine for gonorrhoea
|
Mulloy, W.P. |
|
1989 |
7 |
2 |
p. 176-177 2 p. |
artikel |
21 |
DNA encoding hepatitis B virus antigens and hybrids containing them — expression in yeast for malaria and hepatitis B vaccine preparation
|
|
|
1989 |
7 |
2 |
p. 161- 1 p. |
artikel |
22 |
Dog-distemper virus vaccine preparation from virus inactivated by exposure to binary ethyleneimine or ultraviolet irradiation in the presence of furocoumarin compound
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
23 |
Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients
|
Torre, Donato |
|
1989 |
7 |
2 |
p. 102-103 2 p. |
artikel |
24 |
Editorial
|
|
|
1989 |
7 |
2 |
p. 91- 1 p. |
artikel |
25 |
Effect of formalin treatment on antigenicity of herpes simplex virus type 1 glycoprotein D
|
Ridgeway, P.H. |
|
1989 |
7 |
2 |
p. 187- 1 p. |
artikel |
26 |
Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians
|
Hadler, Stephen C. |
|
1989 |
7 |
2 |
p. 106-110 5 p. |
artikel |
27 |
Efficacy of purified herpes virus glycoprotein vaccines in animal models
|
Mishkin, E. |
|
1989 |
7 |
2 |
p. 185- 1 p. |
artikel |
28 |
Efficacy of yeast-derived glycoprotein B of herpes simplex virus (HSV) on the development of herpetic lesion after intravaginal challenge with HSV type 2
|
Kino, Yoichiro |
|
1989 |
7 |
2 |
p. 185- 1 p. |
artikel |
29 |
Epidemiology and control of sexually transmitted diseases: the global picture
|
Meheus, André |
|
1989 |
7 |
2 |
p. 174- 1 p. |
artikel |
30 |
Evaluation in animal models of genetically engineered herpes simplex virus R7020, a prototype HSV vaccine
|
Meignier, Bernard |
|
1989 |
7 |
2 |
p. 186- 1 p. |
artikel |
31 |
Experimental syphilis vaccines: aro-Salmonella typhimurium expressing recombinant Treponema pallidum antigens
|
Strugnell, R. |
|
1989 |
7 |
2 |
p. 180- 1 p. |
artikel |
32 |
Expression of a poliovirus type 1 neutralization epitope on a diphtheria toxin fusion protein
|
Phalipon, A. |
|
1989 |
7 |
2 |
p. 132-136 5 p. |
artikel |
33 |
Expression of human papillomavirus genes in cervical tissue and their roles in malignant transformation
|
Schoolnik, Gary K. |
|
1989 |
7 |
2 |
p. 183- 1 p. |
artikel |
34 |
Expression of precore-core or preS1-preS2-S genes of hepatitis B virus in vertebrate, e.g. mouse NIH3T3, cell culture
|
|
|
1989 |
7 |
2 |
p. 162- 1 p. |
artikel |
35 |
Factors affecting the transmission rates of genital herpes: considerations for designing vaccine field trials
|
Corey, L. |
|
1989 |
7 |
2 |
p. 186- 1 p. |
artikel |
36 |
Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines
|
Lambré, Claude R. |
|
1989 |
7 |
2 |
p. 104-105 2 p. |
artikel |
37 |
Formation and characterization of FeLV ISCOMs
|
Åkerblom, L. |
|
1989 |
7 |
2 |
p. 142-146 5 p. |
artikel |
38 |
Genes encoding Mycobacterium tuberculosis protein antigens useful for tuberculosis vaccine preparation and therapy
|
|
|
1989 |
7 |
2 |
p. 161- 1 p. |
artikel |
39 |
Glycosylated and non-glycosylated proteins of HSV-1: relevance to vaccine development
|
Skinner, G.R.B. |
|
1989 |
7 |
2 |
p. 187- 1 p. |
artikel |
40 |
Herpes simplex vaccines, current status and future prospects
|
Meignier, Bernard |
|
1989 |
7 |
2 |
p. 184- 1 p. |
artikel |
41 |
HIV antigens and their variability
|
Weiss, R.A. |
|
1989 |
7 |
2 |
p. 188- 1 p. |
artikel |
42 |
HIV-1 epitope expression on a chimaeric poliovirus vaccine vector
|
Evans, David |
|
1989 |
7 |
2 |
p. 189-190 2 p. |
artikel |
43 |
HIV virus envelope polypeptides, variants and antibodies used in immune disease, e.g. AIDS, diagnosis, therapy and vaccine production
|
|
|
1989 |
7 |
2 |
p. 162- 1 p. |
artikel |
44 |
ICRC ‘anti-leprosy vaccine’
|
Deo, M.G. |
|
1989 |
7 |
2 |
p. 92-93 2 p. |
artikel |
45 |
Identification of IgA immunogenic proteins in chlamydial and herpes simplex virus type II infections by Western blotting
|
Lehtinen, M. |
|
1989 |
7 |
2 |
p. 179- 1 p. |
artikel |
46 |
Immune responses to a 104-mer synthetic peptide of the major internal protein, gag (p24) of the human immunodeficiency virus (HIV-1)
|
Sia, D.Y. |
|
1989 |
7 |
2 |
p. 190- 1 p. |
artikel |
47 |
Immune response to immunostimulatory complexes prepared from human immunodeficiency virus and the external envelope glycoprotein
|
Pyle, S.W. |
|
1989 |
7 |
2 |
p. 190- 1 p. |
artikel |
48 |
Immunity to chlamydial infections and the outlook for vaccination
|
Taylor-Robinson, D. |
|
1989 |
7 |
2 |
p. 177- 1 p. |
artikel |
49 |
Immunogenicity of herpes simplex virus glycoprotein gB-1-related protein produced in yeast
|
Kino, Yoichiro |
|
1989 |
7 |
2 |
p. 155-160 6 p. |
artikel |
50 |
Immunogenicity of peptide fusions to hepatitis B core antigen
|
Stahl, Stephen |
|
1989 |
7 |
2 |
p. 182- 1 p. |
artikel |
51 |
Immunological principles of vaccine design
|
Virelizier, Jean-Louis |
|
1989 |
7 |
2 |
p. 174- 1 p. |
artikel |
52 |
Immunology of HIV
|
Essex, M. |
|
1989 |
7 |
2 |
p. 188- 1 p. |
artikel |
53 |
International testing of vaccine candidates for HIV: scientific, ethical and legal aspects
|
Esparza, J. |
|
1989 |
7 |
2 |
p. 181- 1 p. |
artikel |
54 |
Intranasal immunization with proteoliposomes protects against influenza
|
El Guink, Nadia |
|
1989 |
7 |
2 |
p. 147-151 5 p. |
artikel |
55 |
ISCOM technology and the presentation of synthetic peptides
|
Howard, C.R. |
|
1989 |
7 |
2 |
p. 182- 1 p. |
artikel |
56 |
Large-scale production, purification and immunological analysis of vaccinia recombinant derived HIV-1 gp160
|
Barrett, N. |
|
1989 |
7 |
2 |
p. 189- 1 p. |
artikel |
57 |
Lymphocyte proliferative responses to chlamydial antigens in patients with ocular chlamydial infections
|
Mabey, D.C.W. |
|
1989 |
7 |
2 |
p. 179- 1 p. |
artikel |
58 |
Molecular biology of gonococcal porin protein P.I, a candidate vaccine component
|
Carbonetti, Nicholas |
|
1989 |
7 |
2 |
p. 175- 1 p. |
artikel |
59 |
Neutralizing epitopes on the major outer membrane protein of Chlamydia trachomatis
|
Conlan, J.W. |
|
1989 |
7 |
2 |
p. 178- 1 p. |
artikel |
60 |
New cholera vaccines
|
Holmgren, Jan |
|
1989 |
7 |
2 |
p. 94-96 3 p. |
artikel |
61 |
New immunosuppressive peptides useful as FLV, HIV and HTLV vaccines and for producing antibodies for detecting leukaemia and other cancers
|
|
|
1989 |
7 |
2 |
p. 161- 1 p. |
artikel |
62 |
New plasmid containing genes for nontoxic forms of Escherichia coli enterotoxin and transformed cells useful in vaccines against diarrhoea, especially in pigs
|
|
|
1989 |
7 |
2 |
p. 161- 1 p. |
artikel |
63 |
New retrovirus related to HIV virus-1 from T-lymphocyte cell culture derived from paraparesis patients after activation
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
64 |
Novel reactors for vaccines
|
Clyde, Robert |
|
1989 |
7 |
2 |
p. 191- 1 p. |
artikel |
65 |
Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. I. Cross-reacting antigens of members of family Vibrionaceae and the vaccines
|
Čižnǎr, I. |
|
1989 |
7 |
2 |
p. 111-116 6 p. |
artikel |
66 |
Oral cholera vaccines containing B-subunit—killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family
|
Clemens, John D. |
|
1989 |
7 |
2 |
p. 117-120 4 p. |
artikel |
67 |
Oral Immunization Symposium
|
Edelman, Robert |
|
1989 |
7 |
2 |
p. 166-167 2 p. |
artikel |
68 |
Polypeptides reactive with anti-human lymphocyte T4 for use in HIV virus, e.g. AIDS, vaccine production; monoclonal antibody production and hybridoma construction
|
|
|
1989 |
7 |
2 |
p. 162- 1 p. |
artikel |
69 |
Poor immunogenicity as the reason for the ineffectiveness of a glycoprotein subunit vaccine for genital herpes
|
Ashley, R. |
|
1989 |
7 |
2 |
p. 184-185 2 p. |
artikel |
70 |
Potential of immunosomes, liposomes and virosomes in infections with HIV
|
Hildebrand, Goran D. |
|
1989 |
7 |
2 |
p. 191- 1 p. |
artikel |
71 |
Potential of the anti-idiotype approach for the development of an anti-HIV vaccine
|
Dalgleish, A.G. |
|
1989 |
7 |
2 |
p. 189- 1 p. |
artikel |
72 |
Preliminary studies towards the development of a subunit cytomegalovirus vaccine
|
Billstrom, M. |
|
1989 |
7 |
2 |
p. 190-191 2 p. |
artikel |
73 |
Preparation and characterization of pilus synthetic peptide-major iron-regulating protein conjugate vaccine for the prevention of gonococcal infections
|
Dupuy, M. |
|
1989 |
7 |
2 |
p. 176- 1 p. |
artikel |
74 |
Preparation of a subunit vaccine against herpes simplex
|
Talei, G.R. |
|
1989 |
7 |
2 |
p. 187- 1 p. |
artikel |
75 |
Preparation of immune complex herpes simplex vaccine using human sera
|
Shariff, D. |
|
1989 |
7 |
2 |
p. 187- 1 p. |
artikel |
76 |
Presentation of Chlamydia trachomatis epitopes on a poliovirus vaccine vector
|
Burke, K.L. |
|
1989 |
7 |
2 |
p. 177- 1 p. |
artikel |
77 |
Prevention of Chlamydia infections by oral immunization: an effective immunoprophylatic approach for pulmonary and genital infection
|
LaScolea Jr., Leonard J. |
|
1989 |
7 |
2 |
p. 178- 1 p. |
artikel |
78 |
Problems and prospects for the development of a vaccine against gonorrhoea
|
Heckels, John E. |
|
1989 |
7 |
2 |
p. 175- 1 p. |
artikel |
79 |
Production of a hepatitis B virus surface antigen polypeptide and vaccine protein sequence
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
80 |
Production of recombinant Chlamydia trachomatis serovar D major outer membrane protein
|
Maclean, I. |
|
1989 |
7 |
2 |
p. 179-180 2 p. |
artikel |
81 |
Protection against genital herpes simplex virus (HSV) infection and disease with a recombinant gD glycoprotein vaccine
|
Burke, R.L. |
|
1989 |
7 |
2 |
p. 184- 1 p. |
artikel |
82 |
Protective capacity of a ribosomal vaccine against Candida albicans
|
Dussourd d'Hinterland, L. |
|
1989 |
7 |
2 |
p. 177- 1 p. |
artikel |
83 |
Putative failures of recombinant DNA hepatitis B vaccines
|
Arya, S.C. |
|
1989 |
7 |
2 |
p. 164-165 2 p. |
artikel |
84 |
Recombinant avipox virus and expression vector plasmid pNZ180, etc., useful in Marek disease, infectious laryngotracheobronchitis, infectious coryza and coccidioidosis recombinant vaccine production
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
85 |
Recombinant bluetongue virus protein production in insect cells, e.g. Spodoptera frugiperda; application in vaccine manufacture
|
|
|
1989 |
7 |
2 |
p. 161- 1 p. |
artikel |
86 |
Recombinant hepatitis B surface antigen (Re-HBs)
|
Bumelis, V. |
|
1989 |
7 |
2 |
p. 183- 1 p. |
artikel |
87 |
Regression of bovine lymphosarcoma by treatment with cell-wall skeleton of Nocardia rubra
|
Onuma, Misao |
|
1989 |
7 |
2 |
p. 121-124 4 p. |
artikel |
88 |
Report on follow-up of consorts at risk immunized with Skinner vaccine
|
Skinner, G.R.B. |
|
1989 |
7 |
2 |
p. 185- 1 p. |
artikel |
89 |
Selection and suitability of adjuvants
|
Stewart-Tull, D.E.S. |
|
1989 |
7 |
2 |
p. 174- 1 p. |
artikel |
90 |
Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine
|
Osterhaus, A. |
|
1989 |
7 |
2 |
p. 137-141 5 p. |
artikel |
91 |
Seroprevalence of lymphogranuloma venereum agents in northern Nigeria: a preliminary study
|
Eghafona, N.O. |
|
1989 |
7 |
2 |
p. 179- 1 p. |
artikel |
92 |
Serum and vaginal fluid antibodies against the gonococcal major iron-regulated protein in women with pelvic inflammatory disease or uncomplicated infection
|
Morse, S.A. |
|
1989 |
7 |
2 |
p. 175- 1 p. |
artikel |
93 |
Sexually-transmitted disease vaccine requirements: a US perspective
|
Alexander, E.R. |
|
1989 |
7 |
2 |
p. 181- 1 p. |
artikel |
94 |
Specificity of serum immunoglobulin G subclass response to gonorrhoea in women
|
Ison, C.A. |
|
1989 |
7 |
2 |
p. 176- 1 p. |
artikel |
95 |
Stability and safety of a chlamydial live vaccine against enzootic abortion of ewes
|
Rodolakis, Annie |
|
1989 |
7 |
2 |
p. 178- 1 p. |
artikel |
96 |
Stability of an antifertility vaccine consisting of gonadotropin subunits linked to tetanus toxoid
|
Alam, Anis |
|
1989 |
7 |
2 |
p. 129-131 3 p. |
artikel |
97 |
Studies on vaccination against HIV and FIV
|
Jarrett, W. |
|
1989 |
7 |
2 |
p. 188- 1 p. |
artikel |
98 |
Sustained release immunity from adjuvanted vaccines
|
Brancq, B. |
|
1989 |
7 |
2 |
p. 182- 1 p. |
artikel |
99 |
Synthetic anti-caries peptide vaccine preparation active against Streptococcus mutans; monoclonal antibody preparation and hybridoma construction
|
|
|
1989 |
7 |
2 |
p. 162- 1 p. |
artikel |
100 |
Synthetic peptide corresponding to HIV virus glycoprotein 160 envelope sequence which activates T-lymphocytes against HIV proliferation and may be used in an AIDS vaccine
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
101 |
Towards an AIDS vaccine - recombinant Ty: HIV virus-like particles
|
Adams, S. |
|
1989 |
7 |
2 |
p. 189- 1 p. |
artikel |
102 |
Vaccination against papovavirus-induced tumours using vaccinia recombinants expressing non-structural proteins
|
Lathe, R. |
|
1989 |
7 |
2 |
p. 183- 1 p. |
artikel |
103 |
Vaccine for immunization against a parasitic worm Dirofilaria immitis or A. conium comprising genetically engineered mutants Caenorhabditis elegans and Caenorhabditis briggsae
|
|
|
1989 |
7 |
2 |
p. 162- 1 p. |
artikel |
104 |
Vector containing yeast arg3 regulatory region used for production of hepatitis B virus surface antigen for use in vaccine
|
|
|
1989 |
7 |
2 |
p. 163- 1 p. |
artikel |
105 |
Viral Hepatitis and Liver Disease
|
Hilleman, Maurice R. |
|
1989 |
7 |
2 |
p. 165- 1 p. |
artikel |
106 |
Zwitterionic-detergent-extracted subunit HSV-1 vaccine preparations and their effect on HSV-1 latency in mice
|
Al-Ghamdi, A. |
|
1989 |
7 |
2 |
p. 186- 1 p. |
artikel |